Tompkins Financial’s Astrana Health ASTH Stock Holding History

Tompkins Financial’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-31	Closed	-$769	–	680
2025 Q4	$769	Buy	+31	New	+$823	﹤0.01%	610

Other funds holding ASTH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Tompkins Financial's ASTH Position: Q1 2026 in Review

Tompkins Financial sold out of Astrana Health (ASTH) in Q1 2026, closing a stake of 31 shares — an estimated $769 sold.

Tompkins Financial first reported a position in ASTH in Q4 2025 and held it in 1 quarter. The position peaked at $769 in Q4 2025. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

Tompkins Financial reported no remaining Astrana Health position as of Q1 2026 after selling out during the quarter.
Tompkins Financial sold 31 Astrana Health shares in Q1 2026, an estimated $769.
Tompkins Financial first reported a position in Astrana Health in Q4 2025 and held it in 1 quarter.
Tompkins Financial's Astrana Health position peaked at $769 in Q4 2025.
171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Tompkins Financial's 13F filing for Q1 2026, filed 9 Apr 2026.